UCB Proof of Concept Study in Patients With Primary Sjögren's Syndrome

NCT02610543 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

27

Enrollment

INDUSTRY

Sponsor class

Stopped Study stopped prematurely due to enrolment challenges.

Conditions

Primary Sjögren's Syndrome

Interventions

DRUG: UCB5857
DRUG: Placebo

Sponsor

UCB Celltech

Collaborators

[object Object]